Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQLE | Q14534 | 4/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ICMT | O60725 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889907 | 0.88 | PTPN1 (0.51) | SQLEPTPN1KDM1AALOX15ALDH1A1 | |
| SCHEMBL8907996 | 0.84 | KDM1A (0.57) | SQLEPTPN1KDM1AKMT2AKDM4E | |
| SCHEMBL1658396 | 0.84 | KDM1A (0.41) | SQLEPTPN1KDM1AKMT2AKDM4E | |
| SCHEMBL1658397 | 0.84 | KDM1A (0.41) | SQLEPTPN1KDM1AKMT2AKDM4E | |
| SCHEMBL889910 | 0.83 | SQLE (0.39) | SQLEPTPN1KDM1AALOX15ALDH1A1 | |
| SCHEMBL23787675 | 0.81 | PTPN1 (0.49) | SQLEPTPN1KDM1AALOX15ALDH1A1 | |
| SCHEMBL8978511 | 0.81 | KDM1A (0.63) | SQLEPTPN1KDM1AALOX15ALDH1A1 | |
| SCHEMBL8978515 | 0.81 | KDM1A (0.63) | SQLEPTPN1KDM1AALOX15ALDH1A1 | |
| SCHEMBL3376001 | 0.81 | LSS (0.40) | SQLEKDM1AKMT2AMAPTMEN1 | |
| SCHEMBL3375999 | 0.81 | LSS (0.40) | SQLEKDM1AKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9193872-B2 | Photo-crosslinkable antifouling compositions, films obtained from said compositions, and corresponding uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-11-24 | — | — | US | disclosed |
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) | 2011-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268689-A1 | PHOTO-CROSSLINKABLE ANTIFOULING COMPOSITIONS, FILMS OBTAINED FROM SAID COMPOSITIONS, AND CORRESPONDING USES | ALG1, ALG8, PHOSPHO1 | SQLE 94/4885PTPN1 3168/4885KDM1A 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.